WORK SMARTER......NOT HARDER....
WORK SMARTER..NOT HARDER It's So Simple To Earn $2,000 - $5,000 Per Week Nowadays... We're searching for only 10 elite individuals with the work ethic necessary to generate a cash-flow for themselves of $2,000 - $5,000 per week, and to increase that to over $20,000 per month, in as little as four to six months. And you know what? If you really have a burning desire and commitment, we guarantee you that you'll reach this explosive income! Can you read a short script to our qualified leads, and then turn the interested prospects over to our electronic sales medium? (you will not be required to do any selling.)Do you have the self-discipline to ignore the TV for a couple of hours per day? Are you looking for a legitimate home-based business opportunity, that is not multi-level marketing, or a chain-letter scheme? If you would like to build an amazing income that will grow lightning-fast and have you profit $1,000.00 every time only one prospect makes a purchase, then this is for you! You can build the business under our guidance and support without having to attend meetings or sell people things they don't need. Call NOW our TOLL FREE, PRE-RECORDED Message:1-888-780-7191 We market a real product, that pays real commissions to you,$1,000.00 per sale, just for making the initial contacts. With our turn-key lead generation systems you'll always talk to people who actually WANT to talk to you. You have nothing to lose, there's no risk involved, nor is there any obligation whatsoever, and you may be qualified to earn thousands of extra dollars per month! So call now! The call is FREE, and there is absolutely no obligation, So what have you got to lose? Call Toll Free 1-888-780-7191 P.S. You literally have a once-in-a-lifetime opportunity to GET INVOLVED NOW! Don't let this one go by. You have absolutely nothing to lose! This could be the most fascinating and profitable business of your life! Please, serious inquiries only.
Re: Slander & Defamation?
At 06:46 PM 3/28/00 -0500, Declan McCullagh wrote: >Actually Mattel yesterday was talking about a class action suit against >the *cphack mirror site operators*. Another example of "Law in the Corporate Interest". And people wonder why I am an anarchist... --- | Terrorists - The Boogiemen for a new Millennium. | |"The moral PGP Diffie taught Zimmermann unites all| Disclaimer: | | mankind free in one-key-steganography-privacy!" | Ignore the man | | | behind the keyboard.| | http://www.ctrl-alt-del.com/~alan/ |[EMAIL PROTECTED]|
Re: AMD to incorporate EMBASSY technology (maybe)
At 07:40 PM 3/28/00 -0500, Wei Dai wrote: >I've already decided not to buy anything from Intel again (more because >of their lack of driver support than anything else). If AMD really >follows though on this deal I'm going to have a really hard time buying >my next computer. Linux runs on the alpha. (Or if you have even more money, Solaris.) Or PowerPC. --- | Terrorists - The Boogiemen for a new Millennium. | |"The moral PGP Diffie taught Zimmermann unites all| Disclaimer: | | mankind free in one-key-steganography-privacy!" | Ignore the man | | | behind the keyboard.| | http://www.ctrl-alt-del.com/~alan/ |[EMAIL PROTECTED]|
Re: AMD to incorporate EMBASSY technology (maybe)
On Tue, Mar 28, 2000 at 04:16:39PM -0500, Peter Gutmann wrote: > (For people who don't know what EMBASSY is, it's a kind of combination of > Clipper and DIVX, although recently they've tried to deemphasise this since > noone was buying it - see earlier posts to cypherpunks on this topic. Maybe > the press release wasn't by Wave after all but set up by Intel to make their > PIII serial number look good in comparison). I couldn't find the earlier posts on this subject. A search for "embassy and wave" at http://www.inet-one.com/cypherpunks/ produced only one relevant result. There is some technical information about EMBASSY at http://www.wave.com/technology/embassytc3.html. It certainly looks very, very bad. Look at this section for example: Each EMBASSY is loaded prior to shipment with a unique triplet of DES keys in the cryptographic module. The cryptographic module is protected by a state machine to guarantee secure storage of the secret keys of each EMBASSY. Keys may be loaded into the unit and used to cipher data and keys, but there is no facility to read keys out of the key memory. (end quote) So Wave wants to have secret keys embeded in every computer that only they have access to. How could this possibly contribute to "security and privacy"? (And there is much more. Read the document and find out for your self.) I've already decided not to buy anything from Intel again (more because of their lack of driver support than anything else). If AMD really follows though on this deal I'm going to have a really hard time buying my next computer.
Re: Slander & Defamation?
Actually Mattel yesterday was talking about a class action suit against the *cphack mirror site operators*. I kid you not. -Declan At 18:28 3/28/2000 -0500, Paul Spirito wrote: >On 28 Mar 2000 13:19:42 -0500, >Jered Floyd <[EMAIL PROTECTED]> wrote: > > > Then you should sue them. People keep talking about attacking the > > censorware vendors over issues like this, but nobody has yet to do so. > > Why not? Not enough free time, I suppose. > >Also a scruple against elevating libel law to British proportions. >However, with Mattel's recent heavyhanded (& successful) tactics against >the authors of cphack, my scruples are at an all-time low. Surely, if >there are no 1A attorneys who would like to attack them, there must be >an ambulence-chaser out for a fat class action suit? > >Paul, >calling all ambulence-chasers! > >"If you get them by the balls, >their hearts and minds will follow."
Re: Slander & Defamation?
On 28 Mar 2000 13:19:42 -0500, Jered Floyd <[EMAIL PROTECTED]> wrote: > Then you should sue them. People keep talking about attacking the > censorware vendors over issues like this, but nobody has yet to do so. > Why not? Not enough free time, I suppose. Also a scruple against elevating libel law to British proportions. However, with Mattel's recent heavyhanded (& successful) tactics against the authors of cphack, my scruples are at an all-time low. Surely, if there are no 1A attorneys who would like to attack them, there must be an ambulence-chaser out for a fat class action suit? Paul, calling all ambulence-chasers! "If you get them by the balls, their hearts and minds will follow."
Re: Slander & Defamation?
At 01:55 PM 3/28/00 -0500, Tim May wrote: >At 12:10 PM -0500 3/28/00, William H. Geiger III wrote: >In a free society, people or other entities may give opinions as they >wish. Including, but not limited to, opinions about restaurants, >movies, companies, sites, books, and so on. There's a case in the news where some Prof. is suing the admin of a teacher-rating site *even though* the site is merely a public space for posting opinions. Guess how the Prof. rated. He's not a constitutional law prof, for sure.
Re: Slander & Defamation?
At 12:10 PM -0500 3/28/00, William H. Geiger III wrote: >I just received the following note: > >I find this to be slanderous, and a defamation of my character, harmful to >both by personal & business reputation. In addition, Microsystems, is >fully aware that my website is not involved in any of the above activities >that they claim. > >If Microsystems wishes to block some or all of my webpages then they >should do so under an appropriate catagory. In a free society, people or other entities may give opinions as they wish. Including, but not limited to, opinions about restaurants, movies, companies, sites, books, and so on. This clearly means that other people or entities can then pay for these opinions, by subscribing to restaurant reviews or with Internet blocking and filtering services. The "reasons" for a review are irrelevant. In a free society, that is. Some here seem to keep forgetting this. --Tim May -- -:-:-:-:-:-:-: Timothy C. May | Crypto Anarchy: encryption, digital money, ComSec 3DES: 831-728-0152 | anonymous networks, digital pseudonyms, zero W.A.S.T.E.: Corralitos, CA | knowledge, reputations, information markets, "Cyphernomicon" | black markets, collapse of governments.
RE: Nym meat (was RE: How to avoid participating in census legall
> Don't take offense at such personal deconstruction. I'm > merely pointing out what we *actually* know, vs. what > is claimed. Your reply was the funniest thing I've read today. "Group of ephemeral psyop pranksters" indeed! == Mark Leighton Fisher Thomson Consumer Electronics [EMAIL PROTECTED] Indianapolis, IN "Their walls are built of cannon balls, their motto is 'Don't Tread on Me'"
Re: Slander & Defamation?
> I find this to be slanderous, and a defamation of my character, harmful to > both by personal & business reputation. In addition, Microsystems, is > fully aware that my website is not involved in any of the above activities > that they claim. Then you should sue them. People keep talking about attacking the censorware vendors over issues like this, but nobody has yet to do so. Why not? Not enough free time, I suppose. --Jered
Slander & Defamation?
I just received the following note: - Start Quote - I thought you might find this interesting... not surprising though unfortunately. The only access I have to the internet is through my dads computer which features the fine product Winproxy :P. Anyhow, when I tried to go to the censorship section of your page when it gave me the following message. "Restricted Page The requested site is not permitted, because WinProxy has determined that it matches the following categories, which have been restricted by your network administrator: Sex, Drugs, Hatespeech, Crime, Extreme" Unless you have pictures of naked women smoking pot while bashing the heads of whatever minority group they don't happen to like, I seriously doubt the accuracy of that message. - End Quote - I find this to be slanderous, and a defamation of my character, harmful to both by personal & business reputation. In addition, Microsystems, is fully aware that my website is not involved in any of the above activities that they claim. If Microsystems wishes to block some or all of my webpages then they should do so under an appropriate catagory. -- --- William H. Geiger IIIhttp://www.openpgp.net Geiger Consulting Data Security & Cryptology Consulting Programming, Networking, Analysis PGP for OS/2: http://www.openpgp.net/pgp.html ---
Investors and Stock Holders, please read
SHAREHOLDER & INVESTOR ALERT! http://204.1.122.12/0482jds852ma/immunis.html ImmuNis Corp a small Biotech Stock with Big Potential. The Stock Savvy Investor Forum recommends that you evaluate the investment potential of ImmuNis Corp shares. ImmuNis Corp (OTCBB: IMMCE), owns a major interest in a new class of oral diabetes medication. The drug is referred to as DIAB II and has been approved for sale in China and is the final stages of the application and registration process in Brazil. ImmuNis purchased its 25% interest in the commercial rights to DIAB II in 1998 for territories outside of Oriental Asia. DIAB II is an insulin-receptor sensitizer, a new class of drugs for controlling the chronically high blood sugar levels that typify adult-onset or Type II diabetes. DIAB II works by improving the patient's ability to utilize both endogenous and injected insulin, the hormone that controls blood sugar levels. Adult-Onset Diabetes is an illness affecting more than 15 million Americans and more than 150 million people around the world. The drug -- DIAB II -- provides excellent control of diabetes symptoms without the side-effects of many competing drugs that are already on the market. ImmuNis Corp. has about 8.5 million shares outstanding and at $1.50 per share price has a market capitalization of under $15 million in a market segment where the majority of companies trade with $100 million valuations in anticipation of a new discovery or development. DIAB II confirmed the DIAB II is safe and effective. The market for Type II diabetes drugs is over $15 billion annually. We believe that one should carefully evaluate the potential for a much higher stock market valuation of ImmuNis's share price. Many analysts are pointing out that companies like ImmuNis with the potential of success could produce gains comparable to what has been realized in the Dot Com sector. DIAB II was developed by Biotech Holdings Ltd., a Canadian-based pharmaceutical company, which controls the worldwide manufacturing and marketing rights to the drug. In a June 9, 1999 announcement Biotech also pointed out that there is a sizable and very lucrative market potential for DIAB II in Brazil and throughout Latin America -- that for each one percent of the diabetic population in Brazil, Argentina and Venezuela using DIAB II (a total of 100,000 one-year prescriptions) -- DIAB II sales revenues generated would be over $20,000,000 annually. ImmuNis has a 25% interest in all net revenues from the sale of DIAB II in these Latin American Territories as well as in North America and Europe. In addition to its focus on Latin American markets where license agreements have been completed in Brazil with Biobras, which is the fourth largest insulin manufacturer in the world with 75% of the diabetes medication market in Brazil. Agreements have also been completed in Argentina, Venezuela, Peru and Chile. An agreement with a major (more than $10 billion in sales) pharmaceutical company was announced in September of 1999, that foresees potential licensing of DIAB II, for the U.S. market. Biotech expects to be working closely with this prospective licensing partner to review data and arrange for testing of DIAB II. The goal is to reach a licensing agreement that would provide for testing of DIAB II and filing of an application with the U.S. FDA, with the possibility that other markets could also be included in a final agreement. Biotech Holdings completed the first phase of its drug production facility Canadian Health Protection Branch, that certifies that Biotech has met GMP (Good Manufacture in Richmond, B.C. This notice of approval brings DIAB II to the final stages of entering the market in Brazil and throughout Latin American. Registration dossiers for the sale of DIAB II are now planned for submission in Chile, Argentina, Venezuela and Peru. Registration filings are also expected in the Middle East, Southern Europe and Africa. The DIAB II Brazilian clinical trials provided supplementary information for the regulatory application for approval of DIAB II, in Brazil as a prescription treatment for Type II or Adult-Onset Diabetes. The trial was carried out by one of the largest independent contract research laboratories in Brazil, working with Brazilian doctors specializing in diabetes. The trials showed that during DIAB II treatment that no adverse clinical events were reported. Plasma insulin, HDL/LDL ratio and triglycerides were controlled equally well with DIAB II treatment as on the patients' accustomed medication. The critical Hb A1c measurement showed reduced levels during the course of
